Do microRNA 96, 145 and 221 expressions really aid in Lhe prognosis of prostate carcinoma

• Published in: 亚洲男性学杂志：英文版 2012, Vol.14 (5), p.752-757
• Main Author: Sung Gu Kang Young Ran Ha Seo Jin Kim Seok Ho Kang Hong Seok Park Jeong Gu Lee Jun Cheon
• Format: Article
• Language: English
• Subjects: LHE; microRNA; miRNA; 前列腺癌; 复发间隔; 逆转录聚合酶链反应; 非编码RNA; 预后
• ISSN: 1008-682X; 1745-7262

MicroRNAs （miRs） are small noncoding RNAs that have been reported to be premising diagnostic tools. We used quantitative real-time reverse transcription PCR （RT-qPCR） to analyze differentially expressed miRNAs in prostate tumor samples to determine its prognostic value. From 2007 to 2009, tumor tissues were obtained from 73 radical prostatectomy specimens. Differentially expressed miR-96, -145 and -221 were validated by TaqMan RT-qPCR using all 73 tissues. The prognostic value was assessed in terms of biochemical recurrence using Kaplan-Meier and Cox regression analyses. For our patient cohort, the mean age was 64.7 years （50-76 years） and the mean prostate-specific antigen （PSA） was 7.5 ng m1-1. During the follow-up period （mean, 19.4 months）, 14 of 73 （19.2%） patients developed biochemical recurrence. Expression of miR-96, -145 and -221 correlated strongly with each other, but there were no correlations between miRNA expression and clinicopathologic parameters. Kaplan-Meier survival curves using the log-rank test showed a decreased biochemical recurrence-free interval with pathologic stage （P〈O.O01）. In addition, patients with Gleason scores over 8, compared with those with a Gleason score of 6, showed a decreased biochemical recurrence-free interval in Kaplan-Meier analysis （P=O.O01）. However, expression of miR-96, -145 and -221 did not correlate with the biochemical recurrence interval in Kaplan-Meier survival curves or by multivariate analysis using the Cox proportional hazard regression model, either. In conclusion, we did not observe a significant correlation between the expression of miR-96, -145 and -221 and clinicopathologic parameters. To utilize miRNA as a diagnostic tool in clinical practice, more research is needed to understand miRNA mechanisms, identify miRNA targets, and further characterize miRNA function.